Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KITE-222 |
Synonyms | |
Therapy Description |
KITE-222 comprises autologous T-cells engineered to express a chimeric antigen receptor (CAR) that targets CLL1, potentially resulting in increased toxicity in CLL1-expressing tumor cells (NCI Thesaurus). |